Literature DB >> 24993345

Clinical features of human papilloma virus-related head and neck squamous cell carcinoma of an unknown primary site.

Kenya Kobayashi1, Yuki Saito, Go Omura, Mizuo Ando, Takashi Sakamoto, Tatsuya Yamasoba, Takahiro Asakage.   

Abstract

PURPOSE: Head and neck squamous cell carcinoma of an unknown primary site (HNSCCUP) is a heterogeneous group of tumors that includes the human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma. To investigate the relationship between HNSCCUP and HPV, we reviewed p16 overexpression and HPV DNA in lymph node metastases and examined their correlation with the primary site and clinical features.
MATERIALS AND METHODS: Thirty-three patients with HNSCCUP were retrospectively studied. Dissected neck metastases were analyzed for p16 overexpression by immunohistochemistry, and the presence of HPV DNA was investigated by in situ hybridization.
RESULTS: Of the 33 patients, 8 (24%) exhibited p16 overexpression. p16-positive lymph node metastases contained significantly more HPV DNA and were most frequently associated with occult primary lesions in the oropharynx and a favorable prognosis. Patients with a lower alcohol consumption, only level II/III metastasis, and cystic lymph node metastasis tended to have p16 overexpression.
CONCLUSIONS: This is the first report on the relationship of HNSCCUP with p16 and HPV DNA status in Asian patients. In total, 24% of the HNSCCUP patients were p16 positive. p16 overexpression in neck metastasis was predictive of both an occult primary lesion in the oropharynx and an association with HPV infection. Alcohol consumption, location, and features of neck metastasis were correlated with p16 expression.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24993345     DOI: 10.1159/000363190

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  7 in total

Review 1.  The prevalence of human papillomavirus in squamous cell carcinoma of unknown primary site metastatic to neck lymph nodes: a systematic review.

Authors:  Paolo Boscolo-Rizzo; Lea Schroeder; Salvatore Romeo; Michael Pawlita
Journal:  Clin Exp Metastasis       Date:  2015-09-10       Impact factor: 5.150

Review 2.  Clinical features and treatment strategy for HPV-related oropharyngeal cancer.

Authors:  Kenji Okami
Journal:  Int J Clin Oncol       Date:  2016-07-05       Impact factor: 3.402

3.  Factors Influencing the Outcome of Head and Neck Cancer of Unknown Primary (HNCUP).

Authors:  Matthias Balk; Robin Rupp; Konstantinos Mantsopoulos; Matti Sievert; Magdalena Gostian; Moritz Allner; Philipp Grundtner; Markus Eckstein; Heinrich Iro; Markus Hecht; Antoniu-Oreste Gostian
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

4.  Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection.

Authors:  Lars Axelsson; Jan Nyman; Hedda Haugen-Cange; Mogens Bove; Leif Johansson; Shahin De Lara; Anikó Kovács; Eva Hammerlid
Journal:  J Otolaryngol Head Neck Surg       Date:  2017-06-10

5.  The impact of the patient's condition, diagnostic procedures and treatment on the survival of carcinoma of unknown primary site patients.

Authors:  Karolina Dorobisz; Iwona Wlodarska-Polinska; Katarzyna Pazdro-Zastawny; Tomasz Rutkowski; Piotr Palka; Tomasz Dworzecki; Tomasz Zatonski
Journal:  Cancer Manag Res       Date:  2019-07-16       Impact factor: 3.989

6.  Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).

Authors:  Matthias Balk; Robin Rupp; Konstantin Mantsopoulos; Moritz Allner; Philipp Grundtner; S K Mueller; Maximilian Traxdorf; Markus Eckstein; Stefan Speer; Sabine Semrau; Rainer Fietkau; Heinrich Iro; Markus Hecht; Antoniu-Oreste Gostian
Journal:  BMC Cancer       Date:  2021-11-18       Impact factor: 4.430

7.  Cervical lymph node carcinoma metastasis from unknown primary site: a retrospective analysis of 154 patients.

Authors:  Yan Wang; Sha-Sha He; Yong Bao; Xiu-Yu Cai; Hai-Yang Chen; Xing-Li Yang; Dan-Ming Chen; Li-Xia Lu; Yong Chen
Journal:  Cancer Med       Date:  2018-04-02       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.